ArticleBMC cancer2015

TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.

Loay Kassem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.